ConductScience.org, home

Paper37208596

The comparative effectiveness of migraine preventive drugs: a systematic review and network meta-analysis.

Lampl C and 10 others. J Headache Pain, 2023. Cited by 112 papers, by iCite.

Cite this record

ConductScience Library. The comparative effectiveness of migraine preventive drugs: a systematic review and network meta-analysis. Papers, record 37208596. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37208596

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The comparative effectiveness of migraine preventive drugs: a systematic review and network meta-analysis.
PubMed
Journal
J Headache Pain
PubMed
Year
2023
PubMed
Publication types
Systematic Review, Journal Article, Network Meta-Analysis
PubMed
Citations, by iCite
112
iCite
Relative citation ratio, by iCite
20.4
iCite
Revised in PubMed
2025-06-23
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lampl CChristian
2MaassenVanDenBrink AAntoinette
3Deligianni CIChristina I
4Gil-Gouveia RRaquel
5Jassal TTanvir
6Sanchez-Del-Rio MMargarita
7Reuter UUwe
8Uluduz DDerya
9Versijpt JJan
10Zeraatkar DDena
11Sacco SSimona

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Valproic AcidMajor topic
Migraine DisordersMajor topic
Adult
Humans
Topiramate
Gabapentin
Calcitonin Gene-Related Peptide
Amitriptyline
Antibodies, Monoclonal

Source PubMed

Download CSV of topics

References112

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135690723European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention - 2022 update.J Headache Pain2022https://conductscience.org/library/papers/35690723PubMed
220813784Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS).Cephalalgia2011https://conductscience.org/library/papers/20813784PubMed
329368949Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition.Cephalalgia2018https://conductscience.org/library/papers/29368949PubMed
431612482A Randomized Phase 2 Study of Erenumab for the Prevention of Episodic Migraine in Japanese Adults.Headache2019https://conductscience.org/library/papers/31612482PubMed
521070231Amitriptyline in the prophylactic treatment of migraine and chronic daily headache.Headache2011https://conductscience.org/library/papers/21070231PubMed
620961988Tricyclic antidepressants and headaches: systematic review and meta-analysis.BMJ2010https://conductscience.org/library/papers/20961988PubMed
77872882Migraine prophylaxis with divalproex.Arch Neurol1995https://conductscience.org/library/papers/7872882PubMed
829939406Botulinum toxins for the prevention of migraine in adults.Cochrane Database Syst Rev2018https://conductscience.org/library/papers/29939406PubMed
93902723A comparison of naproxen sodium to propranolol hydrochloride and a placebo control for the prophylaxis of migraine headache.Headache1985https://conductscience.org/library/papers/3902723PubMed
1025127173Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study.Lancet Neurol2014https://conductscience.org/library/papers/25127173PubMed
1112503978Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial.JAMA2003https://conductscience.org/library/papers/12503978PubMed
128902255Cyclandelate in the prophylaxis of migraine: a randomized, parallel, double-blind study in comparison with placebo and propranolol. The Study group.Cephalalgia1996https://conductscience.org/library/papers/8902255PubMed
1330529648GRADE approach to rate the certainty from a network meta-analysis: addressing incoherence.J Clin Epidemiol2019https://conductscience.org/library/papers/30529648PubMed
1435760451Theory and practice of Bayesian and frequentist frameworks for network meta-analysis.BMJ Evid Based Med2023https://conductscience.org/library/papers/35760451PubMed
1534323290Efficacy and safety of fremanezumab for episodic migraine prevention: Multicenter, randomized, double-blind, placebo-controlled, parallel-group trial in Japanese and Korean patients.Headache2021https://conductscience.org/library/papers/34323290PubMed
1623406477Amitriptyline vs divalproate in migraine prophylaxis: a randomized controlled trial.Acta Neurol Scand2013https://conductscience.org/library/papers/23406477PubMed
1719393844Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.Clin Ther2009https://conductscience.org/library/papers/19393844PubMed
1825107879Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention.Neurology2014https://conductscience.org/library/papers/25107879PubMed
1915096395Topiramate in migraine prevention: results of a large controlled trial.Arch Neurol2004https://conductscience.org/library/papers/15096395PubMed
2018436948GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.BMJ2008https://conductscience.org/library/papers/18436948PubMed

See all 112 referencesDownload CSV of references

Cited by77

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 112 citations.

PMIDTitleJournalYearIn PapersSource
42768771Factors Impacting the Telephone Follow-Up Response Rate in Patients With Migraine Without Aura: A Cross-Sectional Study of 1299 Females.Pain Res Manag2026https://conductscience.org/library/papers/42768771PubMed
42741009
A multidisciplinary multicentric approach to the identification of predictive biomarkers of response to erenumab - the protocol of the phase 4, European, open-label controlled trial of the BIOMIGA project.
Front Neurol2026https://conductscience.org/library/papers/42741009PubMed
42717153Effectiveness of Rimegepant for the Acute Treatment of Migraine Among Participants Using Different Types of Preventive Therapy: Analyses from CONFIDENCE.Neurol Ther2026https://conductscience.org/library/papers/42717153PubMed
42591761Phenotype-guided selection of venlafaxine and topiramate for vestibular migraine: a narrative review.Front Neurosci2026https://conductscience.org/library/papers/42591761PubMed
42484949Non-Pharmacological Treatments of Migraine: Current Evidence and Clinical Practice.Curr Pain Headache Rep2026https://conductscience.org/library/papers/42484949PubMed
42440212Safety and Effectiveness of Pain Medications for Migraine Management During Pregnancy and Lactation.Paediatr Drugs2026https://conductscience.org/library/papers/42440212PubMed
42356466Therapeutic Overlap Between Bipolar Disorder and Migraine: A Systematic Review of Pharmacological Trials.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42356466PubMed
42327808Evaluating the efficacy of rimegepant as a preventive treatment for chronic and episodic migraine: a three-month longitudinal retrospective cohort study.Front Neurol2026https://conductscience.org/library/papers/42327808PubMed
42237015Cost-Utility Analysis of Calcitonin Gene-Related Peptide Monoclonal Antibodies for Patients with Episodic Migraine Headache in the USA.Pharmacoeconomics2026https://conductscience.org/library/papers/42237015PubMed
42163197Prophylactic efficacy and safety of valproate versus topiramate for migraine: a systematic review.BMC Neurol2026https://conductscience.org/library/papers/42163197PubMed
42113558Associations between psychedelic use and migraine history in Swedish twins.J Psychopharmacol2026https://conductscience.org/library/papers/42113558PubMed
42067810Real-world effectiveness of onabotulinumtoxinA as first-line treatment in chronic migraine and sequential transition to anti-CGRP monoclonal antibodies: a retrospective multicenter study.BMC Neurol2026https://conductscience.org/library/papers/42067810PubMed
42042754
Comparing the Efficacy and Safety of Anti-CGRP Monoclonal Antibodies Versus Topiramate for Migraine Prophylaxis: Six-Month, Real-World, Intention-to-Treat Retrospective Evidence from the GRASP Study Group.
Neurol Int2026https://conductscience.org/library/papers/42042754PubMed
42017407Effectiveness of galcanezumab versus topiramate, amitriptyline, and other select traditional oral migraine preventives with evidence of efficacy: 3-Month results from the TRIUMPH study.Headache2026https://conductscience.org/library/papers/42017407PubMed
41908273Efficacy of Petasites hybridus in migraine prophylaxis: the first real-world study.Front Neurol2026https://conductscience.org/library/papers/41908273PubMed
41893566OnabotulinumToxinA Reduces Pharmacological Burden in Chronic Migraine Patients: A Two-Center Prospective Cohort Study.Toxins (Basel)2026https://conductscience.org/library/papers/41893566PubMed
41872760The effect of targeted upper cervical musculoskeletal management on the frequency and burden of migraine headache in adults - a single cohort pilot study.J Man Manip Ther2026https://conductscience.org/library/papers/41872760PubMed
41829891Migraine and the Gut-Brain Axis-The Role of Microbiome-Targeted Biotics.Nutrients2026https://conductscience.org/library/papers/41829891PubMed
41827347Neurologic Symptoms and Cerebrovascular Events During Atogepant Therapy: A Case Series with Contextual Comparison with a Non-Gepant-Treated Migraine Cohort.J Clin Med2026https://conductscience.org/library/papers/41827347PubMed
41703442Diagnosis challenges and accessibility barriers to migraine management in Southeast Asia: results from the South-East Asia Local breAch on MigraiNe Treatment (SEALANT) study.J Headache Pain2026https://conductscience.org/library/papers/41703442PubMed

See all 77 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AGTR1185PubTator's text mininghttps://conductscience.org/library/genes/185NCBI Gene
CALCA796PubTator's text mininghttps://conductscience.org/library/genes/796NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37208596

GET https://conductscience.org/api/papers/v1/37208596/references?page=2